Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Kurian

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
The Journal of Clinical Psychiatry|July 8, 2011
Concise Associated Symptoms Tracking scale: a brief self-report and clinician rating of symptoms associated with suicidalityMadhukar H Trivedi, Stephen R Wisniewski, David W Morris, et al.
Forensic Science International. Genetics|November 22, 2025
Pharmabiome analyses in tandem with chemometrics can help trace the provenance of falsified medicines: A proof-of-concept studyCarla Perez-Mon, Alberto Roncone, Aiman Abrahim, et al.
The American Journal of Psychiatry|May 4, 2011
Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized studyA John Rush, Madhukar H Trivedi, Jonathan W Stewart, et al.
Human Brain Mapping|June 3, 2015
Test-retest reliability of freesurfer measurements within and between sites: Effects of visual approval processZafer Iscan, Tony B Jin, Alexandria Kendrick, et al.
Journal of Psychiatric Research|February 4, 2017
A comparison of structural connectivity in anxious depression versus non-anxious depressionLauren Delaparte, Fang-Cheng Yeh, Phil Adams, et al.
Depression and Anxiety|October 20, 2015
A COMPREHENSIVE EXAMINATION OF WHITE MATTER TRACTS AND CONNECTOMETRY IN MAJOR DEPRESSIVE DISORDERDoreen M Olvet, Lauren Delaparte, Fang-Cheng Yeh, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 30, 2018
Pretreatment and early-treatment cortical thickness is associated with SSRI treatment response in major depressive disorderElizabeth A Bartlett, Christine DeLorenzo, Priya Sharma, et al.
Journal of Affective Disorders|May 24, 2011
Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED reportWilliam V Bobo, Helen Chen, Madhukar H Trivedi, et al.
Molecular Psychiatry|August 8, 2019
Discovery and replication of cerebral blood flow differences in major depressive disorderCrystal M Cooper, Cherise R Chin Fatt, Peiying Liu, et al.
Psychophysiology|December 22, 2016
Demonstrating test-retest reliability of electrophysiological measures for healthy adults in a multisite study of biomarkers of antidepressant treatment responseCraig E Tenke, Jürgen Kayser, Pia Pechtel, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
The Journal of Clinical Psychiatry|July 8, 2011
Concise Associated Symptoms Tracking scale: a brief self-report and clinician rating of symptoms associated with suicidalityMadhukar H Trivedi, Stephen R Wisniewski, David W Morris, et al.
Forensic Science International. Genetics|November 22, 2025
Pharmabiome analyses in tandem with chemometrics can help trace the provenance of falsified medicines: A proof-of-concept studyCarla Perez-Mon, Alberto Roncone, Aiman Abrahim, et al.
The American Journal of Psychiatry|May 4, 2011
Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized studyA John Rush, Madhukar H Trivedi, Jonathan W Stewart, et al.
Human Brain Mapping|June 3, 2015
Test-retest reliability of freesurfer measurements within and between sites: Effects of visual approval processZafer Iscan, Tony B Jin, Alexandria Kendrick, et al.
Journal of Psychiatric Research|February 4, 2017
A comparison of structural connectivity in anxious depression versus non-anxious depressionLauren Delaparte, Fang-Cheng Yeh, Phil Adams, et al.
Depression and Anxiety|October 20, 2015
A COMPREHENSIVE EXAMINATION OF WHITE MATTER TRACTS AND CONNECTOMETRY IN MAJOR DEPRESSIVE DISORDERDoreen M Olvet, Lauren Delaparte, Fang-Cheng Yeh, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 30, 2018
Pretreatment and early-treatment cortical thickness is associated with SSRI treatment response in major depressive disorderElizabeth A Bartlett, Christine DeLorenzo, Priya Sharma, et al.
Journal of Affective Disorders|May 24, 2011
Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED reportWilliam V Bobo, Helen Chen, Madhukar H Trivedi, et al.
Molecular Psychiatry|August 8, 2019
Discovery and replication of cerebral blood flow differences in major depressive disorderCrystal M Cooper, Cherise R Chin Fatt, Peiying Liu, et al.
Psychophysiology|December 22, 2016
Demonstrating test-retest reliability of electrophysiological measures for healthy adults in a multisite study of biomarkers of antidepressant treatment responseCraig E Tenke, Jürgen Kayser, Pia Pechtel, et al.
Pageof 5